4//SEC Filing
Tyler Julie L. 4
Accession 0001415889-22-001746
CIK 0000001800other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 8:31 PM ET
Size
14.9 KB
Accession
0001415889-22-001746
Insider Transaction Report
Form 4
Tyler Julie L.
SENIOR VICE PRESIDENT
Transactions
- Tax Payment
Common shares without par value
2022-02-22$116.79/sh−466$54,424→ 35,165 total - Award
Option (right to buy)
2022-02-18+48,852→ 48,852 totalExercise: $117.58From: 2023-02-18Exp: 2032-02-17→ Common Shares (48,852 underlying) - Award
Common shares without par value
2022-02-18+10,482→ 36,254 total - Tax Payment
Common shares without par value
2022-02-21$116.79/sh−342$39,942→ 35,631 total - Tax Payment
Common shares without par value
2022-02-19$116.79/sh−281$32,818→ 35,973 total - Sale
Common shares without par value
2022-02-22$119.29/sh−462$55,114→ 34,703 total
Holdings
- 9,160(indirect: By Trust)
Common shares without par value
Footnotes (4)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.2904 to $119.302, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]Balance in the Abbott Laboratories Stock Retirement Trust as of February 18 2022.
- [F4]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 16,284 on February 18, 2023, 16,284 on February 18, 2024 and 16,284 on February 18, 2025.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001867573
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 8:31 PM ET
- Size
- 14.9 KB